跳至主要内容
临床试验/NCT06286215
NCT06286215尚未招募不适用

Registry of Patients With Plasma Cell Disorders

Siriraj Hospital0 个研究点目标入组 750 人开始时间: 2024年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
750
主要终点
register the plasma cell disorder patients

研究概览

简要总结

The goal of this observational study is to register patients with plasma cell disorders. The main questions it aims to answer are:

  • The incidence of plasma cell disorders both before and after malignancy
  • Time to progression of monoclonal gammopathy of undetermined significant (MGUS) or smoldering multiple myeloma (SMM) to light chain amyloidosis or multiple myeloma (MM)
  • Progression free survival (PFS)
  • overall survival
  • factors influencing overall survival, progression-free survival, and time to progression
  • Symptoms and signs of the disease during the diagnosis and relapse phases, including the causes of mortality in plasma cell disorder patients.
  • genetic characteristics of plasma cell disorder
  • cost-effectiveness of treatment in Thailand Participants will be collected the data of baseline diagnosis, treatment, treatment results of all admission and follow-up visits from hospital medical record.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Both existing and newly diagnosed patients with plasma cell disorders, including monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, POEMS, light chain amyloidosis, solitary plasmacytoma, and multiple myeloma, according to the diagnostic criteria of the International Myeloma Working Group 2014
  • Aged 18 years and above

排除标准

  • insufficient data needed for analysis

结局指标

主要结局

register the plasma cell disorder patients

时间窗: 10 years

register the plasma cell disorder patients

次要结局

  • overall survival(10 years)
  • influencing factors(10 years)
  • Progression free survival(10 years)
  • incidence of plasma cell disorders(10 years)
  • cost-effectiveness(10 years)
  • Time to progression(10 years)
  • Symptoms and signs(10 years)
  • genetic characteristics(10 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chutima Kunacheewa

lecturer

Siriraj Hospital

相似试验